The Proteocyte AI Team

An experienced Management team and a world renowned Scientific and Clinical Advisory Board, working together to provide healthcare professionals access to more accurate information and to improve outcomes for patients at risk of cancer.

Our Team

Anthony Morlandt

Anthony Morlandt

Interim Chief Executive Officer

MD, DDS

Barrie Renick

Barrie Renick

Chief Medical Officer

BSc, DDS, Dip Oral Path, Dip Oral Surgery, MRDC(C)

John Jordan

John Jordan

Chief Financial Officer & Chief Operating Officer

MBA, CPA, CMA

David Mock

David Mock

Co-Medical Director

DDS, PhD, FRCD(C)

Kenneth Pritzker

Kenneth Pritzker

Co-Medical Director

MD, FRCPC, FCAP

Jason Hwang

Jason Hwang

Principal Scientist & Straticyte Manager

PhD

Board of Directors

Steven G Arless

Chairman of the Board

Mr. Arless is currently the MedTech Entrepreneur-in-Residence at Centech. As a Canadian entrepreneur in the biomedical technology industry, he has directed and created several medical device companies, from inception to major financing and public stock offerings. He served as CEO of several medical device companies including CryoCath Technologies, CadrioInsight and Resonant Medical, in addition to advancing new medical devices from R&D to commercialization and global sales marketing.

Anthony Morlandt

Director

Dr. Morlandt currently serves as Chief of the Section of Oral Oncology within the Department of Oral and Maxillofacial Surgery at the University of Alabama at Birmingham (UAB) Medicine and is an academic head and neck surgeon. He is the Director of the Head and Neck Oncology Fellowship Program at UAB and an Associate Scientist in the Cancer Chemoprevention Program with the UAB Comprehensive Cancer Center.

Barrie Renick

Director

Dr. Renick has a broad-based oral surgeon with an interest in oral disease, cysts, and tumors. He has been in private practice in Newmarket and a Staff surgeon at Southlake Hospital for over 25 years. He is the only dentist in Canada with dual specialty training in both oral surgery and oral pathology. His training includes experience at Toronto General and Toronto Western Hospitals, The Wellesley Hospital, Sick Kids, Sunnybrook Hospital, Odette Cancer Clinic, Princess Margaret Hospital, and the Sunnybrook Interdisciplinary Mouth Clinic.

Carlo Sistilli

Director

Mr. Sistilli has been serving as Chief Financial Officer of Arista Homes Limited for 14 years and his responsibilities include overseeing the Finance, Accounting and IT areas, as well as due diligence and analysis of land purchases and various other investments. He has held a variety of Senior Positions in the Accounting and Finance Areas during his professional career. As the Controller and part of the Senior Management Team of a $1 Billion Regional Trust Company, he was part of the team to facilitate the successful sale of the Trust Company to Manulife Financial. He also had a Private Accounting Practice/Consulting firm providing services to Small Business Clients and IT Project Management. He spent 5 years as CFO of an Internet Start-up, which provided innovative finance solutions using the internet in the automotive retail sector. As a Founder and member of the Senior Management Team, he was a key player in taking the company public on the Alberta Ventures Exchange (Now TSX Ventures Exchange). He was responsible for the Finance, Accounting and Administration of the company during his tenure, including a member of the due diligence process for the analysis and purchase of other companies in Canada and the US..

John Jordan

Director

Mr. Jordan has held several positions as CFO including two subsidiaries of US public companies, LandCanada and FNF Canada. In addition, he was the founding CFO of a Canadian financial services technology company that was acquired by Fidelity National Financial, Inc. He started his career in public accounting and has worked with many companies in a variety of industries. With more than 20 years’ experience working with entrepreneurs, he brings a wealth of “hands on” financial and operational experience. He understands what it takes to create and build successful technology businesses. He has a well-rounded business knowledge with specific strengths in start ups, growth and acquisitions strategies, business valuations, and financial management.

Scientific and Clinical Advisors

K.W. Michael Siu, PhD, FCIC, FRSC

VP-Research and Innovation
University of Windsor

Ian Witterick, MD, MSc, FRCSC

Chief, Professor and Chair
Otolaryngology-Head & Neck Surgery
Mount Sinai Hospital and University of Toronto

Ranju Ralhan, PhD, FNAMS

Professor
Otolaryngology-Head & Neck Surgery
University of Toronto

Michael West, PhD

Scientific and Business Advisor